Objective To explore the relationship between different diagnostic criteria (ATPIII2002, IDF2005 and CDS2007 criteria) for metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD).
Methods A total of 666 elderly males admitted to West China Hospital for routine physical examination were involved in this study in May, 2010. The diagnostic agreement rates of different criteria were compared, along with the relationship between different diagnostic criteria for MS and NALFD.
Results The diagnostic agreement of CDS2007 criteria with either IDF2005 or ATPIII2002 criteria was good. However, the agreement of ATPIII2002 with IDF2005 was compromised. The prevalence of NAFLD in MS group was significantly higher than that of non-MS group (P lt;0.01). On the basis of CDS2007 criteria, there was significant correlation between NAFLD and MS (P lt;0.000).
Conclusion There is a close relation between NAFLD and all three diagnostic criteria of MS. NAFLD is one of the most important risk factors of MS. The diagnostic agreement of CDS2007 criteria with the other two is good, and there is significant correlation between NAFLD and criteria CDS2007 of MS. CDS2007 is found to be of high accuracy and applicability in the diagnosis of MS in Chinese population including the elderly.
Citation：
XU Yuanning,LIN Xiufang,HUANG Dejia. Relationship between Different Diagnostic Criteria for Metabolic Syndrome and Non-alcoholic Fatty Liver Disease in the Elderly Male. Chinese Journal of Evidence-Based Medicine, 2011, 11(11): 1255-1257. doi: 10.7507/1672-2531.20110212
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
| 1. |
1 Hamaguchi M, Kojima T, Takeda N,
et al
. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Intern Med
, 2005, 143: 722-728.
|
| 2. |
2 Huang HL, Lin WY, Lee LT,
et al
. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
Obes Surg
, 2007, 17(11): 1457- 1463.
|
| 3. |
5 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adult s ( Adult Treatment Panel III ).
JAMA
, 2001, 285: 2486-2497.
|
| 4. |
10 Isomaa B, Almgren P, Tuomi T,
et al
. Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Diabetes Care
, 2001, 24: 683-689.
|
| 5. |
11 Lindh M, Hannoun C, Dhillon AP,
et al
. Core promoter mutationsand genotypes in relation to virus replication and liver damage in East Asian hepatitis B virus carriers.
J Infect Dis
, 1999, 179 (4): 775-782.
|
| 6. |
李锋, 范建高, 蔡晓波. 非酒精性脂肪性肝病致代谢异常. 肝脏, 2006, 11(1): 7-11.
|
| 7. |
程晔, 张舵舵. 非酒精性脂肪肝病与代谢综合征相关性. 中国老年学杂志. 2008, 28(24): 2481-2482.
|
| 8. |
International Diabetes Federation. The IDF consensus worldwide Definition of the metabolic syndrome. 2005. Available from: URL:http://www.idf.org.
|
| 9. |
宋秀霞, 纪立农. 国际糖尿病联盟代谢综合征的全球共识定义. 中华糖尿病杂志, 2005, 13: 175-177.
|
| 10. |
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪肝诊断标准. 中华肝脏病杂志, 2001, 6(9): 325.
|
| 11. |
黄悦勤, 李立明, 王滨有. 临床流行病学. 北京: 人民卫生出版社, 2002.
|
- 1. 1 Hamaguchi M, Kojima T, Takeda N,
et al
. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Intern Med
, 2005, 143: 722-728.
- 2. 2 Huang HL, Lin WY, Lee LT,
et al
. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.
Obes Surg
, 2007, 17(11): 1457- 1463.
- 3. 5 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adult s ( Adult Treatment Panel III ).
JAMA
, 2001, 285: 2486-2497.
- 4. 10 Isomaa B, Almgren P, Tuomi T,
et al
. Cardiovascular morbidity and mortality associated with the metabolic syndrome.
Diabetes Care
, 2001, 24: 683-689.
- 5. 11 Lindh M, Hannoun C, Dhillon AP,
et al
. Core promoter mutationsand genotypes in relation to virus replication and liver damage in East Asian hepatitis B virus carriers.
J Infect Dis
, 1999, 179 (4): 775-782.
- 6. 李锋, 范建高, 蔡晓波. 非酒精性脂肪性肝病致代谢异常. 肝脏, 2006, 11(1): 7-11.
- 7. 程晔, 张舵舵. 非酒精性脂肪肝病与代谢综合征相关性. 中国老年学杂志. 2008, 28(24): 2481-2482.
- 8. International Diabetes Federation. The IDF consensus worldwide Definition of the metabolic syndrome. 2005. Available from: URL:http://www.idf.org.
- 9. 宋秀霞, 纪立农. 国际糖尿病联盟代谢综合征的全球共识定义. 中华糖尿病杂志, 2005, 13: 175-177.
- 10. 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪肝诊断标准. 中华肝脏病杂志, 2001, 6(9): 325.
- 11. 黄悦勤, 李立明, 王滨有. 临床流行病学. 北京: 人民卫生出版社, 2002.
Journal type citation(4)
| 1. | 何绍亚. 幽门螺旋杆菌感染对DNA甲基化影响与胃癌相关性研究进展. 国际感染病学(电子版). 2019(03): 228-229 .  Baidu Scholar | |
| 2. | 郭珊岚，王卫. CDH1基因甲基化状态与结直肠癌临床病理特征及预后的相关性分析. 安徽医药. 2016(05): 891-894 . Baidu Scholar | |
| 3. | 方日，王小文. CDH1基因甲基化状态与结直肠癌临床病理特征及预后的相关性研究. 海南医学. 2016(11): 1779-1782 . Baidu Scholar | |
| 4. | 马勇，吴新民，郭亚民. 胃癌转移相关分子标志物的研究进展. 现代肿瘤医学. 2014(12): 3017-3020 . Baidu Scholar | |
Other types of references(5)
| 1. | 黄晓磊. 上皮钙黏蛋白(CDH1)基因启动子甲基化与胃癌关系的meta分析[D]. 福建医科大学. 2014. Baidu Scholar | |
| 2. | 桑怡. 慢性萎缩性胃炎不同中医证型与胃黏膜DNA甲基化水平差异研究[D]. 浙江中医药大学. 2015. Baidu Scholar | |
| 3. | 李小杰. SFRP1基因与肺腺癌的肿瘤发生及转移的关系研究[D]. 南方医科大学. 2017. Baidu Scholar | |
| 4. | 马志明. CaMKKβ抑制剂STO-609诱导胃腺癌细胞凋亡的机制研究[D]. 吉林大学. 2017. Baidu Scholar | |
| 5. | 贺梅娟. 慢性萎缩性胃炎癌前病变中医证候分布特点及益气化瘀解毒法干预机制的研究[D]. 北京中医药大学. 2015. Baidu Scholar | |
